Back
Snowflake, Inc. 10K Form
Sell
30
SNOW
Snowflake, Inc.
Last Price:
$225.17
Seasonality Move:
-20.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-31 | 10Q | SNOW/Snowflake, Inc. Quarterly |
| 2023-12-01 | 10Q | SNOW/Snowflake, Inc. Quarterly |
| 2023-08-31 | 10Q | SNOW/Snowflake, Inc. Quarterly |
| 2023-06-02 | 10Q | SNOW/Snowflake, Inc. Quarterly |
| 2022-12-02 | 10Q | SNOW/Snowflake, Inc. Quarterly |
| 2022-09-01 | 10Q | SNOW/Snowflake, Inc. Quarterly |
Receive SNOW News And Ratings
See the #1 stock for the next 7 days that we like better than SNOW
SNOW Financial Statistics
Sales & Book Value
| Annual Sales: | $3.6B |
|---|---|
| Cash Flow: | $113.6M |
| Price / Cash Flow: | 97.94 |
| Annual Sales: | $6.24 |
| Price / Book: | 36.11 |
Profitability
| EPS (TTM): | -4.03550 |
|---|---|
| Net Income (TTM): | $-1.3B |
| Gross Margin: | $2.4B |
| Return on Equity: | -52.27% |
| Return on Assets: | -16.08% |
Snowflake, Inc. Earnings Forecast
Key Snowflake, Inc. Financial Ratios
-
The Gross Profit Margin over the past 11 years for SNOW is 65.40%.
-
The Selling, General & Administrative Expenses for SNOW have been equal to 57.48% of Gross Profit Margin.
-
The Research & Development expenses have been 48.27% of Revenue.
-
The Net Earning history of SNOW is -35.55% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 2 years.
Snowflake, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | IT Services |
| Sector: | Information Technology |
| Current Symbol: | SNOW |
| CUSIP: | 833445 |
| Website: | snowflake.com |
Debt
| Debt-to-Equity Ratio: | 1.26 |
|---|---|
| Current Ratio: | 1.32 |
| Quick Ratio: | 1.27 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 137.9 |
SNOW Technical Analysis vs Fundamental Analysis
Sell
30
Snowflake, Inc. (SNOW)
is a Sell
Is Snowflake, Inc. a Buy or a Sell?
-
Snowflake, Inc. stock is rated a SellThe current Snowflake, Inc. [SNOW] share price is $225.10. The Score for SNOW is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.